Because NEU1 and Trem2 are implicated in neurodegenerative/neuro-inflammatory diseases, including Alzheimer’s disease and sialidosis, modulating NEU1 activity may present a therapeutic approach to broadly regulate microglia-mediated neuroinflammation. Here, NEU1 is linked to early-onset autosomal dominant Alzheimer disease.